Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Neural Regeneration Research|July 8, 2022
The neuroprotective effects of oxygen therapy in Alzheimer's disease: a narrative reviewCui Yang, Qiu Yang, Yang Xiang, et al.Investigative Ophthalmology & Visual Science|February 25, 2005
Mechanisms of apoptosis in human retinal pigment epithelium induced by TNF-alpha in conditions of heavy metal ion deficiencyJun-Hai Yang, Wei-Dong Le, Scott F Basinger, et al.Neuroscience Letters|June 1, 2005
Genetic analysis of parkin co-regulated gene (PACRG) in patients with early-onset parkinsonismHao Deng, Wei-Dong Le, Wen-Jie Xie, et al.Neuro-Signals|January 25, 2012
A mechanistic study of proteasome inhibition-induced iron misregulation in dopamine neuron degenerationXu-ping Li, Wen-jie Xie, Zhen Zhang, et al.Archives of Neurology|March 14, 2007
A family with Parkinson disease, essential tremor, bell palsy, and parkin mutationsHao Deng, Wei-Dong Le, Christine B Hunter, et al.CNS Neuroscience & Therapeutics|July 1, 2015
A New VMAT-2 Inhibitor NBI-641449 in the Treatment of Huntington DiseaseSheng Chen, Xiao-Jie Zhang, Wen-Jie Xie, et al.Chinese Medical Journal|September 10, 2021
Current Alzheimer disease research highlights: evidence for novel risk factorsWilla D Brenowitz, Yang Xiang, Claire T McEvoy, et al.Archives of Neurology|February 16, 2006
Heterogeneous phenotype in a family with compound heterozygous parkin gene mutationsHao Deng, Wei-Dong Le, Christine B Hunter, et al.Journal of Neuroscience Research|July 14, 2005
Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microgliaXuan Liu, Xiao-Lan Fan, Yan Zhao, et al.Nature Genetics|December 24, 2002
Mutations in NR4A2 associated with familial Parkinson diseaseWei-Dong Le, Pingyi Xu, Joseph Jankovic, et al.Pageof 7